Cost of revenue · 2011–2025
Niagen Bioscience cost of revenue
$46.2M+21.6% · FY2025
Niagen Bioscience (NAGE) reported $46.2M in cost of revenue for fiscal 2025, +21.6% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $46.2M | +21.6% | Open → |
| FY20242024-12-31 | $38.0M | +15.9% | Open → |
| FY20232023-12-31 | $32.8M | +12.1% | Open → |
| FY20222022-12-31 | $29.3M | +12.7% | Open → |
| FY20212021-12-31 | $26.0M | +8.2% | Open → |
| FY20202020-12-31 | $24.0M | +16.9% | Open → |
| FY20192019-12-31 | $20.5M | +32.4% | Open → |
| FY20182018-12-31 | $15.5M | +44.6% | Open → |
| FY20172017-12-30 | $10.7M | −4.9% | Open → |
| FY20162016-12-31 | $11.3M | +8.9% | Open → |
| FY20152016-01-02 | $10.4M | +3.6% | Open → |
| FY20142015-01-03 | $10.0M | +42.1% | Open → |
| FY20132013-12-28 | $7.0M | −24.7% | Open → |
| FY20122012-12-29 | $9.3M | +65.5% | Open → |
| FY20112011-12-31 | $5.6M | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +16.2%
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Niagen Bioscience cost of revenue |url=https://companiesranked.com/en/company/niagen-bioscience/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Niagen Bioscience cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/niagen-bioscience/cost-of-revenueBibTeX
@misc{companiesranked-en-company-niagen-bioscience-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{Niagen Bioscience cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/niagen-bioscience/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001386570-26-000013 · March 4, 2026
{{cite web |title=Niagen Bioscience cost of revenue — 10-K (0001386570-26-000013) |url=https://www.sec.gov/Archives/edgar/data/1386570/000138657026000013/cdxc-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.